Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Johannes de Vos

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

Journal of Clinical Oncology

English

Related publications

Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens

English

Kaposi’s Sarcoma: Good Outcome With Doxorubicin, Bleomycin and Vincristine Sulphate (ABV) Chemotherapy and Highly Active Antiretroviral Therapy

South African Medical Journal

Medicine

2017

English

Long-Term Follow Up of Patients With Human Immunodeficiency Virus Infection and Advanced Stage Hodgkin's Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine and Dacarbazine

Haematologica

Hematology

2013

English

A Pilot Trial of Adriamycin, Pembrolizumab, Vinblastine and Dacarbazine (Apvd) for Patients With Untreated Classical Hodgkin Lymphoma

Hematological Oncology

English

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

British Journal of Haematology

Hematology

2018

English

Combination of Idarubicin, Vinblastine, Dacarbazine, and Gemcitabine (IVDG) as Therapy for Elderly Patients With Hodgkin Lymphoma With Cardiac and Pulmonary Comorbidity

Hematological Oncology

English

Immune Reconstitution in HIV-1 Infected Patients Treated for Two Years With Highly Active Antiretroviral Therapy

Journal of Venomous Animals and Toxins Including Tropical Diseases

English

Reduced Relative Dose Intensity of Primary Chemotherapy Does Not Influence Prognosis of Patients With Hodgkin Lymphoma

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia

English

Nivolumab Plus Doxorubicin, Vinblastine and Dacarbazine for Newly Diagnosed Advanced-Stage Classical Hodgkin Lymphoma: Checkmate 205 Cohort D 2-Year Follow-Up

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Johannes de Vos

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

Related publications

Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens

Kaposi’s Sarcoma: Good Outcome With Doxorubicin, Bleomycin and Vincristine Sulphate (ABV) Chemotherapy and Highly Active Antiretroviral Therapy

Long-Term Follow Up of Patients With Human Immunodeficiency Virus Infection and Advanced Stage Hodgkin's Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine and Dacarbazine

A Pilot Trial of Adriamycin, Pembrolizumab, Vinblastine and Dacarbazine (Apvd) for Patients With Untreated Classical Hodgkin Lymphoma

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

Combination of Idarubicin, Vinblastine, Dacarbazine, and Gemcitabine (IVDG) as Therapy for Elderly Patients With Hodgkin Lymphoma With Cardiac and Pulmonary Comorbidity

Immune Reconstitution in HIV-1 Infected Patients Treated for Two Years With Highly Active Antiretroviral Therapy

Reduced Relative Dose Intensity of Primary Chemotherapy Does Not Influence Prognosis of Patients With Hodgkin Lymphoma

Nivolumab Plus Doxorubicin, Vinblastine and Dacarbazine for Newly Diagnosed Advanced-Stage Classical Hodgkin Lymphoma: Checkmate 205 Cohort D 2-Year Follow-Up